Amneal Pharmaceuticals (AMRX) Divestments (2024)
Amneal Pharmaceuticals' (AMRX) quarterly Divestments came in at $7.0 million in Q4 2024.
Amneal Pharmaceuticals (AMRX) Divestments (2024) Analysis & Trends
Amneal Pharmaceuticals' Divestments history runs 1 years deep, the most recent figure standing at $7.0 million for Q4 2024.
- On a quarterly basis, Divestments changed N/A year-over-year to $7.0 million in Q4 2024; TTM through Dec 2025 was $7.0 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $12.0 million, changed N/A from the prior year.
- Divestments held at $7.0 million in Q4 2024 per AMRX's latest filing.
- Across five years, Divestments topped out at $7.0 million in Q4 2024 and bottomed at $7.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 42.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.28 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.67 Bn | 320.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.01 Mn |